Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioRebalance is a private U.S. consumer health and nutraceutical company that markets BioRebalance Restore, an oral multi-nutrient supplement positioned to support mood, relaxation, sleep, energy, and the gut-liver-brain axis. The company describes the product as being designed by orthomolecular nutritional experts and formulated with amino acids, vitamins, minerals, fatty acids, herbs, and SAM-e. Its commercial focus appears to be direct-to-consumer sales of a single flagship supplement rather than a traditional prescription drug pipeline. BioRebalance operates as an active for-profit company and is best characterized as a supplement brand within health and wellness rather than a biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioRebalance.